Global Health Equity: Cancer Care Outcome Disparities in High-, Middle-, and Low-Income Countries
- PMID: 26578608
- PMCID: PMC5795715
- DOI: 10.1200/JCO.2015.62.2860
Global Health Equity: Cancer Care Outcome Disparities in High-, Middle-, and Low-Income Countries
Abstract
Breakthroughs in our global fight against cancer have been achieved. However, this progress has been unequal. In low- and middle-income countries and for specific populations in high-income settings, many of these advancements are but an aspiration and hope for the future. This review will focus on health disparities in cancer within and across countries, drawing from examples in Kenya, Brazil, and the United States. Placed in context with these examples, the authors also draw basic recommendations from several initiatives and groups that are working on the issue of global cancer disparities, including the US Institute of Medicine, the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, and the Union for International Cancer Control. From increasing initiatives in basic resources in low-income countries to rapid learning systems in high-income countries, the authors argue that beyond ethics and equity issues, it makes economic sense to invest in global cancer control, especially in low- and middle-income countries.
© 2015 by American Society of Clinical Oncology.
Conflict of interest statement
Authors' disclosures of potential conflicts of interest are found in the article online at
Figures
References
-
- Lopes Gde L, Jr, de Souza JA, Barrios C: Access to cancer medications in low- and middle-income countries Nat Rev Clin Oncol 10:314–322,2013 - PubMed
-
- Krieger N: Defining and investigating social disparities in cancer: Critical issues Cancer Causes Control 16:5–14,2005 - PubMed
-
- US Department of Health and Human Services : The Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020. Phase I report: Recommendations for the framework and format of Healthy People 2020. Section IV. Advisory Committee findings and recommendations http://www.healthypeople.gov/sites/default/files/PhaseI_0.pdf
-
- International Agency for Research on Cancer, WHO : GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
-
- Torre LA Bray F Siegel RL, etal: Global cancer statistics, 2012 CA Cancer J Clin 65:87–108,2015 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
